SynsoryBio

Winter 2024Active

"If-then" conditional logic for protein drugs

Save

SynsoryBio

Winter 2024Active

"If-then" conditional logic for protein drugs

Save

Company details

SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.

Location

Boston, MA, USA

Founded

Unknown

Upgrade to Pro, then request the SynsoryBio teardown.

This company does not have a completed analysis yet. Choose a Pro plan first, then use one of your 5 monthly research requests to have our agent investigate SynsoryBio. The full teardown, rebuild plan, and technical specs unlock when it lands.

Use Pro to request the first SynsoryBio teardown and keep the finished report in your account.
Read every completed teardown and rebuild plan already in the database.
Unlock implementation-ready technical specs and 5 fresh research requests each month.

Choose your Pro plan

$20/ month

Find one worth rebuilding, get the teardown, open the implementation-ready specs, and use fresh report requests when you want deeper research.

See Pro plans

Full teardown library

Specs for every company

5 fresh requests / month

CLI for agent imports